Author/Creator: Jungerwirth, Steven - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Jungerwirth, Steven

1. A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy. Issue 12 (December 2016)

Authors:: Kremer, Joel M.; Emery, Paul; Camp, Heidi S.; Friedman, Alan; Wang, Li; Othman, Ahmed A.; Khan, Nasser; Pangan, Aileen L.; Jungerwirth, Steven; Keystone, Edward C.
Journal:: Arthritis & rheumatology
Issue:: Volume 68:Issue 12(2016)
Page Start:: 2867
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high‐fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib. (19th June 2017)

Authors:: Mohamed, Mohamed‐Eslam F.; Jungerwirth, Steven; Asatryan, Armen; Jiang, Ping; Othman, Ahmed A.
Journal:: British journal of clinical pharmacology
Issue:: Volume 83:Number 10(2017)
Page Start:: 2242
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Issue 12 (December 2016)

Authors:: Genovese, Mark C.; Smolen, Josef S.; Weinblatt, Michael E.; Burmester, Gerd R.; Meerwein, Sebastian; Camp, Heidi S.; Wang, Li; Othman, Ahmed A.; Khan, Nasser; Pangan, Aileen L.; Jungerwirth, Steven
Journal:: Arthritis & rheumatology
Issue:: Volume 68:Issue 12(2016)
Page Start:: 2857
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗